We may receive a commission on purchases made from links. A tablet is a great buy if you want the portability of a smartphone in a larger form factor. Whether you need a device that will be great for ...

Icecure Medical ( (ICCM)) just unveiled an update. On December 10, 2025, IceCure Medical announced that its ProSense® Cryoablation technology was featured in four independent studies presented at the ...

Tablet computers are used for countless reasons. They can be portable entertainment centers for everything from movies to books. They can be cheaper than laptops for college students. Even ...

We may receive a commission on purchases made from links. Android tablets, for the most part, can seem like a budget-friendly alternative to iPads, with some models costing half the price or less. And ...

This latest approval further broadens global access to ProSense® and supports IceCure's commercial momentum following the U.S. Food and Drug Administration's ("FDA") recent marketing authorization of ...

IceCure Medical Ltd. (NASDAQ:ICCM), the developer of minimally invasive cryoablation technology that destroys tumors by freezing them, was granted marketing authorization from the U.S. Food and Drug ...

The ProSense® Cryoablation System could be a game changer for women over 70 with early-stage, low-risk breast cancer. For decades, breast cancer treatment has often meant surgery, which can be an ...

The FDA has granted the ProSense Cryoablation System marketing authorization for small, low-risk breast cancers in women at least 70 years of age who receive adjuvant endocrine therapy. The ...

The FDA granted marketing authorization for the ProSense Cryoablation System for small, early-stage breast cancer in older women not suitable for surgery, maker IceCure announced. A minimally invasive ...

IceCure Medical’s tumor-freezing treatment ProSense has nabbed FDA approval, making it the first medical device of its kind to be endorsed for the local treatment of breast cancer. The Israeli medical ...